Incyte Announces Positive CHMP Opinion for Minjuvi® (tafasitamab) for the Treatment of Relapsed or Refractory Follicular Lymphoma (FL)
因塞特(US:INCY) Businesswire·2025-11-17 06:00公司动态 - 公司宣布欧洲药品管理局人用药品委员会对Minjuvi®（tafasitamab）用于治疗复发或难治性滤泡性淋巴瘤给予积极意见 [1]